Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313424490> ?p ?o ?g. }
- W4313424490 endingPage "256" @default.
- W4313424490 startingPage "244" @default.
- W4313424490 abstract "Many studies suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can infect various animals and transmit among animals, and even to humans, posing a threat to humans and animals. There is an urgent need to develop inexpensive and efficient animal vaccines to prevent and control coronavirus disease 2019 (COVID-19) in animals. Rabies virus (RABV) is another important zoonotic pathogen that infects almost all warm-blooded animals and poses a great public health threat. The present study constructed two recombinant chimeric viruses expressing the S1 and RBD proteins of the SARS-CoV-2 Wuhan01 strain based on a reverse genetic system of the RABV SRV9 strain and evaluated their immunogenicity in mice, cats and dogs. The results showed that both inactivated recombinant viruses induced durable neutralizing antibodies against SARS-CoV-2 and RABV and a strong cellular immune response in mice. Notably, inactivated SRV-nCoV-RBD induced earlier antibody production than SRV-nCoV-S1, which was maintained at high levels for longer periods. Inactivated SRV-nCoV-RBD induced neutralizing antibodies against both SARS-CoV-2 and RABV in cats and dogs, with a relatively broad-spectrum cross-neutralization capability against the SARS-CoV-2 pseudoviruses including Alpha, Beta, Gamma, Delta, and Omicron, showing potential to be used as a safe bivalent vaccine candidate against COVID-19 and rabies in animals." @default.
- W4313424490 created "2023-01-06" @default.
- W4313424490 creator A5003986323 @default.
- W4313424490 creator A5007689920 @default.
- W4313424490 creator A5009241426 @default.
- W4313424490 creator A5016289451 @default.
- W4313424490 creator A5021870954 @default.
- W4313424490 creator A5023714188 @default.
- W4313424490 creator A5031045967 @default.
- W4313424490 creator A5034517280 @default.
- W4313424490 creator A5036712029 @default.
- W4313424490 creator A5061388769 @default.
- W4313424490 creator A5066593508 @default.
- W4313424490 creator A5075064575 @default.
- W4313424490 creator A5078204519 @default.
- W4313424490 creator A5080473175 @default.
- W4313424490 creator A5082984637 @default.
- W4313424490 creator A5088520193 @default.
- W4313424490 creator A5091063400 @default.
- W4313424490 date "2023-04-01" @default.
- W4313424490 modified "2023-10-01" @default.
- W4313424490 title "An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV" @default.
- W4313424490 cites W1579010799 @default.
- W4313424490 cites W1930745477 @default.
- W4313424490 cites W1954537726 @default.
- W4313424490 cites W1966754844 @default.
- W4313424490 cites W1989888538 @default.
- W4313424490 cites W2005392544 @default.
- W4313424490 cites W2049173933 @default.
- W4313424490 cites W2067031341 @default.
- W4313424490 cites W2119113392 @default.
- W4313424490 cites W2256756668 @default.
- W4313424490 cites W2547085806 @default.
- W4313424490 cites W2585072088 @default.
- W4313424490 cites W2586765610 @default.
- W4313424490 cites W2648006107 @default.
- W4313424490 cites W2759882827 @default.
- W4313424490 cites W2895067807 @default.
- W4313424490 cites W2900998719 @default.
- W4313424490 cites W2912850482 @default.
- W4313424490 cites W2943739489 @default.
- W4313424490 cites W2979891585 @default.
- W4313424490 cites W2991840702 @default.
- W4313424490 cites W2999176115 @default.
- W4313424490 cites W3007257464 @default.
- W4313424490 cites W3007643904 @default.
- W4313424490 cites W3012650581 @default.
- W4313424490 cites W3013093478 @default.
- W4313424490 cites W3014233146 @default.
- W4313424490 cites W3014989892 @default.
- W4313424490 cites W3022917947 @default.
- W4313424490 cites W3032255042 @default.
- W4313424490 cites W3038870615 @default.
- W4313424490 cites W3042383115 @default.
- W4313424490 cites W3045578670 @default.
- W4313424490 cites W3045724532 @default.
- W4313424490 cites W3048620154 @default.
- W4313424490 cites W3087103595 @default.
- W4313424490 cites W3090844627 @default.
- W4313424490 cites W3092766467 @default.
- W4313424490 cites W3093141020 @default.
- W4313424490 cites W3093931895 @default.
- W4313424490 cites W3096064145 @default.
- W4313424490 cites W3102258632 @default.
- W4313424490 cites W3105398595 @default.
- W4313424490 cites W3117730334 @default.
- W4313424490 cites W3127277789 @default.
- W4313424490 cites W3136676003 @default.
- W4313424490 cites W3148794780 @default.
- W4313424490 cites W3164914349 @default.
- W4313424490 cites W3176552995 @default.
- W4313424490 cites W3212172572 @default.
- W4313424490 cites W4205240144 @default.
- W4313424490 cites W4210330762 @default.
- W4313424490 cites W4210586812 @default.
- W4313424490 cites W4214529646 @default.
- W4313424490 cites W4224950176 @default.
- W4313424490 cites W4225293614 @default.
- W4313424490 cites W4226155367 @default.
- W4313424490 cites W4226303018 @default.
- W4313424490 cites W4280488965 @default.
- W4313424490 cites W4280489222 @default.
- W4313424490 cites W4280542714 @default.
- W4313424490 cites W4281481125 @default.
- W4313424490 cites W4282938654 @default.
- W4313424490 doi "https://doi.org/10.1016/j.virs.2022.12.006" @default.
- W4313424490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36587795" @default.
- W4313424490 hasPublicationYear "2023" @default.
- W4313424490 type Work @default.
- W4313424490 citedByCount "1" @default.
- W4313424490 countsByYear W43134244902023 @default.
- W4313424490 crossrefType "journal-article" @default.
- W4313424490 hasAuthorship W4313424490A5003986323 @default.
- W4313424490 hasAuthorship W4313424490A5007689920 @default.
- W4313424490 hasAuthorship W4313424490A5009241426 @default.
- W4313424490 hasAuthorship W4313424490A5016289451 @default.
- W4313424490 hasAuthorship W4313424490A5021870954 @default.
- W4313424490 hasAuthorship W4313424490A5023714188 @default.